本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

德納維製藥

10.58
-0.3200-2.94%
成交量:384.09萬
成交額:4,068.60萬
市值:12.70億
市盈率:-22.56
高:10.88
開:10.72
低:10.56
收:10.90
資料載入中...
2023/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/06

重要事件披露

Form 8-K - Current report
2023/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/27

重要事件披露

Form 8-K - Current report
2023/05/20

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/04

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/02

重要事件披露

8-K - Current report
2023/05/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals